mVASC

mVASC. Microvascular Tissue Allograft by MVT (Microvascular Tissues) Brought to you by MVT Consultants.

[Audio] We will present an overview of mVASC a revolutionary microvascular tissue allograft developed by M-V-T Consultants. Today we will introduce you to the basics of mVASC discuss its applications and indications and provide trial data and additional resources for those interested in learning more. We will begin with a quick agenda which outlines the topics we will be covering today. We will then move on to understanding what mVASC is and how it works. Next we will explore the various applications and indications for mVASC including its use in wound care. We will provide data and additional resources for those interested in learning more about mVASC. This includes information on the H-I-F-L-O Wound Care Trial as well as additional papers and data on the use of mVASC. Finally we will discuss how to order and access mVASC as well as answer any questions you may have..

[Audio] Our company is dedicated to transforming the microvascular tissue regeneration industry and enhancing the well-being of patients globally by promoting education distribution and community awareness for mVASC our flagship product..

[Audio] We are on slide 4 of our presentation on mVASC the first product of its kind in a new category of regenerative biologics. Our product is a microvascular tissue allograft derived from the cadaver of a deceased donor. mVASC is dehydrated acellular and provided as a sterile 19.5 millimeters disc making it a Human Cellular Tissue Product (HCT/P) regulated by the F-D-A as a 361 product. This means that mVASC can be used for any condition with compromised or deficient microvascular tissue making it a “homologous use” product..

[Audio] We are discussing the unique microvascular tissue allograft called mVASC. This allograft is designed to address compromised microvascular blood flow that contributes to many chronic clinical conditions. When placed on a wound mVASC discs solubilize immediately and coat the wound with the microvascular tissue extracellular matrix. This provides a scaffolding for the growth of new blood vessels and tissue promoting angiogenesis and improved profusion of tissues. The mVASC allograft can be injected for internal wounds such as chronic inflammation and pain or applied to external wounds to replace or support deficient or compromised microvascular tissues. With mVASC patients can experience relief from chronic conditions and improved quality of life..

[Audio] Illustrations of microvascular deficiencies.

[Audio] We design mVASC as a homologous use HCT/P 361 product. It is suitable for use in a variety of healthcare areas including wound care podiatry orthopedics pain management MSK medicine sports medicine and other clinical settings. We design mVASC to improve the circulation and profusion of blood in affected areas leading to improved healing outcomes and better patient outcomes..

[Audio] Our wound care product has been shown to have 9X greater odds of healing compared to the standard of care (S-O-C--). Our research has shown benefits for a variety of conditions including plantar fasciitis neuropathy shoulder rotator cuff patellar tendon knee OA and synovitis..

[Audio] We are pleased to announce that mVASC the microvascular tissue allograft by M-V-T Consultants is now available to government facilities. Government agencies can easily order and use mVASC in multiple locations. At the Department of Defense mVASC is currently on contract and being used in various facilities. It can be easily ordered with the G-P-C program. We are pleased to inform you that mVASC is being evaluated in the vacc (VA Community Care Program) and the TriCare Community Provider Network. Similarly at the Veteran’s Administration mVASC has recently been placed on contract with VA for all facilities. It can be accessed immediately with the G-P-C program and is currently being evaluated in the vacc and the TriCare Community Provider Network. We are confident that mVASC will provide a valuable solution for government agencies looking for an effective microvascular tissue allograft. We are committed to working with government agencies to ensure a seamless and successful implementation of mVASC..

[Audio] We hope that this presentation has been informative and helpful to you. We want to ensure that you have all the necessary information to make informed decisions. If you have any further questions or need additional information please contact your M-V-T Consultant..